Cipla Profit & Loss Annual

Trade
BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | Sector: Biotechnology & Drugs
1,483.50 -22.55 (-1.50%)Updated : 19 Jul 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 25,774.0922,753.1221,763.3419,159.59
Total Revenue 25,774.0922,753.1221,763.3419,159.59
Costof Revenue Total 8,819.579,314.249,560.758,328.64
Gross Profit 16,954.5213,438.8812,202.5910,830.95
Selling/ General/ Admin Expenses Total 4,310.047,507.046,908.866,031.69
Depreciation/ Amortization 1,051.021,017.83987.831,000.57
Unusual Expense( Income) 194.82309.57241.3264.54
Other Operating Expenses Total 6,353.43511.60463.91399.33
Total Operating Expense 20,728.8819,047.0318,430.6015,960.05
Operating Income 5,045.213,706.093,332.743,199.54
Interest Inc( Exp) Net- Non- Op Total -898.802,968.40908.30212.10
Other Net 746.5733.8461.0266.30
Net Income Before Taxes 5,701.904,038.353,493.273,290.06
Provisionfor Income Taxes 1,546.591,202.86933.80888.76
Net Income After Taxes 4,155.312,835.492,559.472,401.30
Minority Interest -32.17-30.98-29.9016.36
Equity In Affiliates -15.90-26.00-128.20-127.90
Net Income Before Extra Items 4,121.552,801.912,516.752,404.87
Net Income 4,121.552,801.912,516.752,404.87
Income Availableto Com Excl Extra Ord 4,121.552,801.912,516.752,404.87
Income Availableto Com Incl Extra Ord 4,121.552,801.912,516.752,404.87
Dilution Adjustment 0.00---
Diluted Net Income 4,121.552,801.912,516.752,404.87
Diluted Weighted Average Shares 80.8080.7680.7480.73
Diluted EPS Excluding Extra Ord Items 51.0134.6931.1729.79
DPS- Common Stock Primary Issue 13.008.505.005.00
Diluted Normalized EPS 52.7737.3733.2830.35
Research Development -3,853.902,656.801,327.30
Interest Exp( Inc) Net- Operating Total -13.6022.5025.50
Gain( Loss)on Saleof Assets -15.8086.8030.10
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,792.85+33.70(1.92%)
474.30+4.20(0.89%)
2,945.95+15.50(0.53%)
157.75-8.60 (-5.17%)
364.50-13.25 (-3.51%)
HomeMarketsPremiumInstant LoanBudget